$ABBV
AI AnalysisGenerated on May 11, 2026
AI Score
Hold$ABBV
AbbVie Inc.
$ABBVNYSEHealthcareMega-Cap
AbbVie is a biopharmaceutical company focused on immunology (Skyrizi, Rinvoq), oncology, neuroscience, and aesthetics (Botox).
Market Cap
$330.0B
Revenue (TTM)
$56.3B
+4.0%
Net Income (TTM)
$5.5B
-10.0%
EPS (TTM)
$3.12
P/E Ratio
58.0
Dividend Yield
3.5%
52-Week Range
$154-$212
Beta
0.62
Dimension Scores
Fundamental
68Technical
62Sentiment
72Risk / Reward
70Momentum
65Financial Health
Profitability
73moderate
Growth
68moderate
Liquidity
78strong
Solvency
70strong
Efficiency
66strong
Valuation, technical analysis, investment thesis, risk assessment and more for $ABBV
Free · No credit card required
Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.